Cell Lines and Clinical Isolates Derived From Ph1-Positive Chronic Myelogenous Leukemia Patients Express C-Abl Proteins With a Common Structural Alteration.

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.82.6.1810
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

A Case of Ph1-Positive Chronic Myelocytic Leukemia Associated With Complex Translocations

Proceedings of the Japan Academy
1976English

Re-Evaluating the Role of BCR/ABL in Chronic Myelogenous Leukemia

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2014English

Denovo BCR-ABL Positive Acute Myelogenous Leukemia in Adult Saudi Patient-A Case Report

Journal of Cancer Prevention & Current Research
2017English

Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia

Cancer Research
Cancer ResearchOncology
2004English

Chronic Myelogenous Leukemia

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Medication Adherence, Molecular Monitoring, and Clinical Outcomes in Patients With Chronic Myelogenous Leukemia in a Large HMO

Journal of the American Pharmacists Association : JAPhA
PharmacologyPharmacy
2017English

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Expressing P190BCR-Abl.

Internal Medicine
Internal MedicineMedicine
2002English

Arginine Butyrate Downregulates P210 BCR-Abl Expression and Induces Apoptosis in Chronic Myelogenous Leukemia Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1998English

Chronic Myelogenous Leukemia Molecular Signature

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy